Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers
dc.contributor.author | Stuve, O | |
dc.contributor.author | Soerensen, PS | |
dc.contributor.author | Leist, T | |
dc.contributor.author | Giovannoni, G | |
dc.contributor.author | Hyvert, Y | |
dc.contributor.author | Damian, D | |
dc.contributor.author | Dangond, F | |
dc.contributor.author | Boschert, U | |
dc.date.accessioned | 2021-01-12T15:13:55Z | |
dc.date.available | 2019-05-07 | |
dc.date.available | 2021-01-12T15:13:55Z | |
dc.date.issued | 2019-06 | |
dc.identifier.issn | 1756-2856 | |
dc.identifier.other | ARTN 1756286419854986 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/69637 | |
dc.relation.ispartof | THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS | |
dc.rights | Attribution-NonCommercial 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/3.0/us/ | * |
dc.subject | cladribine tablets | en_US |
dc.subject | CLARITY | en_US |
dc.subject | CLARITY Extension | en_US |
dc.subject | lymphocytes | en_US |
dc.subject | multiple sclerosis | en_US |
dc.subject | ORACLE-MS | en_US |
dc.subject | subsets | en_US |
dc.title | Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1177/1756286419854986 | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000478587000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 12 | en_US |